6C7G
Crystal structure of human phosphodiesterase 2A with N-(1-adamantyl)-1-(2-chloro-5-isobutoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline-8-carboxamide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.2 |
Synchrotron site | ALS |
Beamline | 5.0.2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-05-06 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.00000 |
Spacegroup name | P 1 |
Unit cell lengths | 56.141, 73.992, 91.743 |
Unit cell angles | 109.48, 91.49, 91.04 |
Refinement procedure
Resolution | 66.130 - 1.680 |
R-factor | 0.199 |
Rwork | 0.197 |
R-free | 0.23350 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.007 |
RMSD bond angle | 1.030 |
Data reduction software | DIALS |
Data scaling software | Aimless (0.5.25) |
Phasing software | PHASER |
Refinement software | PHENIX |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 66.130 | 66.130 | 1.720 |
High resolution limit [Å] | 1.680 | 7.510 | 1.680 |
Rmerge | 0.171 | 0.143 | 0.604 |
Rmeas | 0.235 | 0.199 | 0.827 |
Rpim | 0.161 | 0.138 | 0.562 |
Total number of observations | 260972 | ||
Number of reflections | 146602 | 1750 | 10776 |
<I/σ(I)> | 2.9 | ||
Completeness [%] | 92.4 | 98.6 | 91.2 |
Redundancy | 1.8 | 2.1 | 1.9 |
CC(1/2) | 0.897 | 0.879 | 0.544 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8.4 | 293 | 17-19% PEG3350, 0.2 M magnesium chloride, 0.1 M Tris, pH 8.4 |